Free Trial
ASX:IBX

Imagion Biosystems (IBX) Stock Price, News & Analysis

Imagion Biosystems logo

About Imagion Biosystems Stock (ASX:IBX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10.77 million shs
Average Volume
N/A
Market Capitalization
A$3.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imagion Biosystems and its competitors with MarketBeat's FREE daily newsletter.

IBX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Imagion Biosystems Announces New Securities Quotation
Imagion Biosystems Issues 7.5 Million Unquoted Securities
See More Headlines

IBX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Imagion Biosystems investors own include EMCORE (EMKR), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:IBX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$6.32 million
Net Margins
-265.26%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$5.92 million
Price / Cash Flow
3.00
Book Value
A($0.16) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$3.62 million
Optionable
Not Optionable
Beta
2.05
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (ASX:IBX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners